Regulatory

AHPA, CHPA, CRN, and UNPA say placing ODS under the Office of Nutrition Research would add a layer of bureaucracy. NIH is accepting comments through October 28.

Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.

FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.

The agency’s editorial identifies needs across six areas, including new methods for novel products, gut microbiome data, and AI-supported risk assessment.

The Council for Responsible Nutrition says its Morning Consult survey also found that three in four adults use supplements and that cost is the most commonly cited barrier.

The proposed notification requirement is straightforward, but its legal and commercial consequences are not.

The trade group says the denial does not settle its concerns about a law that limits minors' access to supplements marketed for weight loss or muscle building, and the case now returns to district court.

A year-to-date look at the federal and state measures shaping supplement oversight, access, and classification.

A panel at The Outlook on Active Nutrition discussed quality in sports nutrition focused on testing, liability, and what buyers now expect from suppliers.

Part 2 of our interview with Todd Harrison, co-chair of the FDA practice group at Venable LLP covers preclusion's structural gaps: no defined end point, no tracking registry, and a push for mandatory drug-sponsor engagement.

Todd Harrison, co-chair of the FDA practice group at Venable LLP, details the Dietary Supplement Innovation Act's language, its unintended consequences, and what industry stakeholders should watch for.

Piping Rock Health Products has launched a 300-mg NMN gummy under its Vitafusion brand, arriving less than a year after the FDA reversed its position on whether the ingredient could legally be sold as a dietary supplement.

The Dietary Supplement Innovation Act, introduced by Rep. Harshbarger, would cap indefinite preclusion, require science-based review standards, and open FDA warnings to court challenge.

At the Future Nutra Innovation Summit, Sibyl Swift, PhD, founder and principal of Swift Strategy Group, discusses supplement oversight and unpacks why mandatory product listing divides the industry.

The inaugural Future Nutra Innovation Summit opened with organizers pitching a networking-first alternative to the traditional trade show, followed by an NSF presentation on certification failure rates and consumer trust that set a tone for the rest of the event.

This overview outlines the clinical background, consumer landscape, and technical developments shaping the gluten-free category.

A new request for information, expert roundtable findings, and a transatlantic workshop signal FDA's renewed focus on plant-based drug products.

Congress has pushed back the 0.4 mg THC cap by one month, giving supplement brands additional time before the new hemp definition takes effect.

BBB National Programs’ National Advertising Division upheld Kendal Nutricare's core ingredient claim, but recommended changes to nutrition, breast milk, and brand heritage messaging.

"Adaptogen" has no formal US regulatory definition, but it traces to a specific 1958 scientific origin and a defined set of pharmacological criteria that formulators can use to evaluate ingredient claims.

A newly launched, heat-killed postbiotic ingredient from Superbrewed Food aims to give formulators an alternative to live probiotics that don't require viability management through manufacturing and shelf life.

The ingredient supplier will present a dozen branded ingredients spanning joint, metabolic, and cognitive health categories as the Asia-Pacific supplement market continues to expand.

President Trump announced in a Truth Social post that he will be nominating Heidi Overton, MD, PhD, as FDA's new Commissioner to replace Commissioner Martin Makary who resigned in May.

New program offers product testing database and compliance tools to help retailers distinguish legal kratom products from synthetic compounds.

Ashish Talati discusses the proposed GRAS rule, and what industry needs to understand about complying with the rule should it be finalized.

As a federal THC cap looms, industry leaders weigh in on what the new hemp definition means for brands and formulators.

The proposed rule would end nearly 7 decades of voluntary GRAS notification, a change with direct implications for how supplement and functional food ingredients enter the market.

California is the first state to pass a bill requiring standardized consumer-facing food date labels, with New York in tow. The new labels prescribe terminology for quality or safety-based date labels on food products.